aTYR PHARMA INC
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · San Diego, CA
ATYR chart
What traders are saying about $ATYR
Latest postsaTYR PHARMA INC news
- What Is Behind The Rise In Moderna Stock?
trefis.com ·
- aTyr Pharma Inc (471A.HM) Seasonal returns chart
Yahoo Finance UK ·
- aTyr Pharma files prospectus to sell up to $79.99 million in common stock
Investing.com Nigeria ·
- aTyr Pharma opens $80M share-sale program to extend runway
Dealroom ·
- aTyr Pharma files to offer up to $80M in common stock via ATM program
StreetInsider ·
- Jefferies would earn 3% on stock sales under aTyr Pharma (ATYR)'s proposed offering.
Stock Titan ·
- RBC Capital maintains aTyr Pharma at Sector Perform, lowers price target to $6 from $40
TradingView ·
- aTyr Pharma, Inc. (ATYR) Stock Price, News, Quote & History
Yahoo! Finance Canada ·
- RBC Slashes Price Target on aTyr Pharma to $6 From $40, Keeps Sector Perform, Speculative Risk
marketscreener.com ·
- Wells Fargo maintains aTyr Pharma at Equal-Weight, raises price target to $4 from $1
TradingView ·
- H.C. Wainwright Maintains ATyr Pharma(ATYR.US) With Hold Rating
Moomoo ·
- Piper Sandler lowers aTyr Pharma stock price target on valuation
Investing.com ·
aTYR PHARMA INC key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $190,000 | $235,000 | $353,000 | $10.4M |
| Net income | -$74.1M | -$64.0M | -$50.4M | -$45.3M |
| Diluted EPS | $-0.80 | $-0.86 | $-0.94 | $-1.60 |
| Total assets (year end) | $93.0M | $96.8M | $120.7M | $95.8M |
| Cash and equivalents (year end) | $10.7M | $11.1M | $22.5M | $10.0M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About aTYR PHARMA INC
- Ticker
- ATYR (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- San Diego, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1339970
Frequently asked questions
What exchange is aTYR PHARMA INC listed on?
aTYR PHARMA INC trades on the Nasdaq under the ticker symbol ATYR.
What industry is aTYR PHARMA INC in?
aTYR PHARMA INC is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is aTYR PHARMA INC headquartered?
aTYR PHARMA INC's business address on file with the SEC is in San Diego, CA.
When does aTYR PHARMA INC's fiscal year end?
aTYR PHARMA INC's fiscal year ends on December 31.
How much revenue did aTYR PHARMA INC report?
aTYR PHARMA INC reported $190,000 in revenue for calendar year 2025, according to its SEC filings.